property,axiomValue,count,proLabel,axValLab
obo:RO_0002573,obo:MONDO_0021136,12928,has modifier,rare
obo:RO_0002573,obo:MONDO_0021152,8971,has modifier,inherited
obo:RO_0004026,obo:UBERON_0001016,6457,disease has location,nervous system
obo:RO_0004024,obo:GO_0032502,5453,disease disrupts,developmental process
obo:RO_0004024,obo:GO_0032502,5453,disease causes disruption of,developmental process
obo:RO_0004024,obo:GO_0008283,4649,disease disrupts,cell population proliferation
obo:RO_0004024,obo:GO_0008283,4649,disease disrupts,cell proliferation
obo:RO_0004024,obo:GO_0008283,4649,disease causes disruption of,cell population proliferation
obo:RO_0004024,obo:GO_0008283,4649,disease causes disruption of,cell proliferation
obo:RO_0002573,obo:MONDO_0021140,4419,has modifier,congenital
obo:RO_0004021,obo:GO_0048598,4258,disease caused by disruption of,embryonic morphogenesis
obo:RO_0004021,obo:GO_0048598,4258,disease has basis in disruption of,embryonic morphogenesis
obo:RO_0002573,obo:MONDO_0021127,4118,has modifier,has a syndromic presentation
obo:RO_0004026,obo:UBERON_0001017,3769,disease has location,central nervous system
obo:RO_0004026,obo:UBERON_0007811,3714,disease has location,craniocervical region
obo:RO_0004026,obo:UBERON_0000033,3528,disease has location,head
obo:RO_0004026,obo:UBERON_0002204,3472,disease has location,musculoskeletal system
obo:RO_0004026,obo:UBERON_0000955,3053,disease has location,brain
obo:RO_0004026,obo:UBERON_0002384,2842,disease has location,connective tissue
obo:RO_0004026,obo:UBERON_0001456,2686,disease has location,face
obo:RO_0004026,obo:UBERON_0002104,2538,disease has location,visual system
obo:RO_0004026,obo:UBERON_0004088,2515,disease has location,orbital region
obo:RO_0004026,obo:UBERON_0000019,2481,disease has location,camera-type eye
obo:RO_0004026,obo:UBERON_0010230,2481,disease has location,eyeball of camera-type eye
obo:RO_0004026,obo:UBERON_0001434,2286,disease has location,skeletal system
obo:RO_0002573,obo:PATO_0002097,2190,has modifier,"neoplastic, malignant"
obo:RO_0004026,obo:UBERON_0002416,2118,disease has location,integumental system
obo:RO_0004021,obo:GO_0008152,2009,disease caused by disruption of,metabolic process
obo:RO_0004021,obo:GO_0008152,2009,disease has basis in disruption of,metabolic process
obo:RO_0004024,obo:MF_0000020,1946,disease disrupts,mental process
obo:RO_0004024,obo:MF_0000020,1946,disease causes disruption of,mental process
obo:RO_0004026,obo:UBERON_0000949,1914,disease has location,endocrine system
obo:RO_0004026,obo:UBERON_0002481,1895,disease has location,bone tissue
obo:RO_0004026,obo:UBERON_0001007,1877,disease has location,digestive system
obo:RO_0004026,obo:UBERON_0004535,1813,disease has location,cardiovascular system
obo:RO_0004026,obo:UBERON_0000014,1695,disease has location,zone of skin
obo:RO_0004026,obo:UBERON_0002417,1606,disease has location,abdominal segment of trunk
obo:RO_0004026,obo:UBERON_0000915,1573,disease has location,thoracic segment of trunk
obo:RO_0004026,obo:UBERON_0004122,1537,disease has location,genitourinary system
obo:RO_0004026,obo:UBERON_0002405,1527,disease has location,immune system
obo:RO_0004021,obo:MF_0000020,1493,disease caused by disruption of,mental process
obo:RO_0004021,obo:MF_0000020,1493,disease has basis in disruption of,mental process
obo:RO_0004026,obo:UBERON_0000990,1477,disease has location,reproductive system
obo:RO_0004030,obo:CL_0000066,1452,disease arises from structure,epithelial cell
obo:RO_0004026,obo:UBERON_0000010,1344,disease has location,peripheral nervous system
obo:RO_0004021,obo:GO_0060348,1318,disease caused by disruption of,bone development
obo:RO_0004021,obo:GO_0060348,1318,disease has basis in disruption of,bone development
obo:RO_0004026,obo:UBERON_0002390,1265,disease has location,hematopoietic system
obo:RO_0004026,obo:UBERON_0001008,1187,disease has location,renal system
obo:RO_0004024,obo:GO_0006954,1159,disease disrupts,inflammatory response
obo:RO_0004024,obo:GO_0006954,1159,disease causes disruption of,inflammatory response
obo:RO_0004027,obo:UBERON_0000061,1159,disease has inflammation site,anatomical structure
obo:RO_0004026,obo:UBERON_0007798,1031,disease has location,vascular system
obo:RO_0004026,obo:UBERON_0001630,1027,disease has location,muscle organ
obo:RO_0004026,obo:UBERON_0002049,1024,disease has location,vasculature
obo:RO_0004026,obo:UBERON_0002385,1013,disease has location,muscle tissue
obo:RO_0004026,obo:CL_0000066,1009,disease has location,epithelial cell
obo:RO_0004026,obo:UBERON_0002113,992,disease has location,kidney
obo:RO_0004026,obo:UBERON_0000474,917,disease has location,female reproductive system
obo:RO_0002573,obo:HP_0000007,857,has modifier,Autosomal recessive inheritance
obo:RO_0002573,obo:MONDO_0021128,837,has modifier,has an isolated presentation
obo:RO_0004029,obo:HP_0001250,834,disease has feature,Seizures
obo:RO_0004026,obo:UBERON_0001004,811,disease has location,respiratory system
obo:RO_0004026,obo:UBERON_0000948,777,disease has location,heart
obo:RO_0004024,obo:GO_0050905,766,disease disrupts,neuromuscular process
obo:RO_0004024,obo:GO_0050905,766,disease causes disruption of,neuromuscular process
mondo:disease_has_major_feature,obo:HP_0007313,725,disease has major feature,Cerebral degeneration
mondo:disease_has_major_feature,obo:HP_0100022,704,disease has major feature,Abnormality of movement
obo:RO_0004024,obo:GO_0001503,700,disease disrupts,ossification
obo:RO_0004024,obo:GO_0001503,700,disease causes disruption of,ossification
obo:RO_0002573,obo:PATO_0002096,664,has modifier,"neoplastic, non-malignant"
obo:RO_0004026,obo:UBERON_0000160,643,disease has location,intestine
obo:RO_0004026,obo:UBERON_0000966,617,disease has location,retina
obo:RO_0002573,obo:HP_0000006,616,has modifier,Autosomal dominant inheritance
mondo:disease_has_major_feature,obo:HP_0040064,606,disease has major feature,Abnormality of limbs
obo:RO_0004026,obo:UBERON_0016490,598,disease has location,auditory system
obo:RO_0004024,obo:GO_0007600,584,disease disrupts,sensory perception
obo:RO_0004024,obo:GO_0007600,584,disease causes disruption of,sensory perception
obo:RO_0004026,obo:UBERON_0002368,568,disease has location,endocrine gland
obo:RO_0004026,obo:UBERON_0035639,542,disease has location,ocular adnexa
obo:RO_0004026,obo:UBERON_0000991,528,disease has location,gonad
obo:RO_0004026,obo:UBERON_0001798,519,disease has location,vitreous body
obo:RO_0004026,obo:UBERON_0000079,496,disease has location,male reproductive system
mondo:disease_has_major_feature,obo:MONDO_0020022,495,disease has major feature,central nervous system malformation
obo:RO_0004020,obo:GO_0099080,489,disease has basis in dysfunction of,supramolecular complex
obo:RO_0004020,obo:GO_0043292,488,disease has basis in dysfunction of,contractile fiber
obo:RO_0004029,obo:HP_0003198,488,disease has feature,Myopathy
mondo:disease_has_major_feature,obo:MONDO_0005027,483,disease has major feature,epilepsy
obo:RO_0004020,obo:GO_0043227,480,disease has basis in dysfunction of,membrane-bounded organelle
obo:RO_0004024,obo:GO_0007605,474,disease disrupts,sensory perception of sound
obo:RO_0004024,obo:GO_0007605,474,disease causes disruption of,sensory perception of sound
obo:RO_0004029,obo:MONDO_0005066,467,disease has feature,metabolic disease
obo:RO_0004026,obo:UBERON_0001134,446,disease has location,skeletal muscle tissue
obo:RO_0004029,obo:HP_0000556,445,disease has feature,Retinal dystrophy
obo:RO_0004025,obo:UBERON_0000966,445,disease causes dysfunction of,retina
obo:RO_0004021,obo:GO_0002524,444,disease caused by disruption of,hypersensitivity
obo:RO_0004021,obo:GO_0002524,444,disease has basis in disruption of,hypersensitivity
obo:RO_0004026,obo:GO_0030849,442,disease has location,autosome
obo:RO_0004029,obo:HP_0002027,439,disease has feature,Abdominal pain
obo:RO_0004024,obo:MF_0000008,437,disease disrupts,cognitive process
obo:RO_0004024,obo:MF_0000008,437,disease causes disruption of,cognitive process
obo:RO_0004026,obo:UBERON_0000021,430,disease has location,cutaneous appendage
obo:RO_0004030,obo:CL_0000988,405,disease arises from structure,hematopoietic cell
obo:RO_0004028,obo:NCBITaxon_2,400,realized in response to stimulus,Bacteria
mondo:disease_has_major_feature,obo:HP_0000726,394,disease has major feature,Dementia
obo:RO_0004026,obo:UBERON_0001558,392,disease has location,lower respiratory tract
obo:RO_0004021,obo:GO_0006091,384,disease caused by disruption of,generation of precursor metabolites and energy
obo:RO_0004021,obo:GO_0006091,384,disease has basis in disruption of,generation of precursor metabolites and energy
obo:RO_0004021,obo:GO_0005975,380,disease caused by disruption of,carbohydrate metabolic process
obo:RO_0004021,obo:GO_0005975,380,disease has basis in disruption of,carbohydrate metabolic process
obo:RO_0004026,obo:UBERON_0003134,376,disease has location,female reproductive organ
obo:RO_0002573,obo:HP_0010985,375,has modifier,Gonosomal inheritance
obo:RO_0002573,obo:HP_0001417,371,has modifier,X-linked inheritance
mondo:disease_has_major_feature,obo:MONDO_0005070,360,disease has major feature,neoplasm (disease)
obo:RO_0004029,obo:HP_0000789,359,disease has feature,Infertility
obo:RO_0004024,obo:GO_0006082,355,disease disrupts,organic acid metabolic process
obo:RO_0004024,obo:GO_0006082,355,disease causes disruption of,organic acid metabolic process
obo:RO_0004026,obo:UBERON_0002423,351,disease has location,hepatobiliary system
obo:RO_0004024,obo:GO_0043010,348,disease disrupts,camera-type eye development
obo:RO_0004024,obo:GO_0043010,348,disease causes disruption of,camera-type eye development
obo:RO_0004026,obo:UBERON_0001003,337,disease has location,skin epidermis
obo:RO_0004026,obo:UBERON_0001133,335,disease has location,cardiac muscle tissue
obo:RO_0004026,obo:UBERON_0001711,334,disease has location,eyelid
obo:RO_0004026,obo:UBERON_0002048,332,disease has location,lung
obo:RO_0004022,obo:HP_0002960,331,disease arises from feature,Autoimmunity
obo:RO_0004022,obo:HP_0002960,331,disease has basis in feature,Autoimmunity
obo:RO_0002573,obo:MONDO_0022201,331,has modifier,has treatment by surgery
obo:RO_0004021,obo:GO_0006082,330,disease caused by disruption of,organic acid metabolic process
obo:RO_0004021,obo:GO_0006082,330,disease has basis in disruption of,organic acid metabolic process
obo:RO_0004030,obo:CL_0002494,319,disease arises from structure,cardiocyte
obo:RO_0004026,obo:UBERON_0000165,311,disease has location,mouth
obo:RO_0004029,obo:MONDO_0001517,305,disease has feature,dysentery
obo:RO_0004030,obo:CL_0008019,302,disease arises from structure,mesenchymal cell
obo:RO_0002573,obo:HP_0011463,297,has modifier,Childhood onset
obo:RO_0004026,obo:CL_0000738,292,disease has location,leukocyte
mondo:disease_has_major_feature,obo:HP_0001317,290,disease has major feature,Abnormal cerebellum morphology
mondo:disease_has_major_feature,obo:HP_0001317,290,disease has major feature,Abnormality of the cerebellum
obo:RO_0004021,obo:GO_0034101,289,disease caused by disruption of,erythrocyte homeostasis
obo:RO_0004021,obo:GO_0034101,289,disease has basis in disruption of,erythrocyte homeostasis
obo:RO_0004024,obo:GO_0006629,287,disease disrupts,lipid metabolic process
obo:RO_0004024,obo:GO_0006629,287,disease causes disruption of,lipid metabolic process
obo:RO_0004020,obo:GO_0005739,286,disease has basis in dysfunction of,mitochondrion
obo:RO_0004021,obo:GO_0072358,285,disease caused by disruption of,cardiovascular system development
obo:RO_0004021,obo:GO_0072358,285,disease has basis in disruption of,cardiovascular system development
obo:RO_0004021,obo:GO_0009117,284,disease caused by disruption of,nucleotide metabolic process
obo:RO_0004021,obo:GO_0009117,284,disease has basis in disruption of,nucleotide metabolic process
obo:RO_0004026,obo:UBERON_0002037,283,disease has location,cerebellum
obo:RO_0002573,obo:MONDO_0021141,280,has modifier,acquired
obo:RO_0004024,obo:GO_0009117,279,disease disrupts,nucleotide metabolic process
obo:RO_0004024,obo:GO_0009117,279,disease causes disruption of,nucleotide metabolic process
obo:RO_0004026,obo:UBERON_0000065,274,disease has location,respiratory tract
obo:RO_0004028,obo:NCBITaxon_10239,266,realized in response to stimulus,Viruses
obo:RO_0004028,obo:NCBITaxon_10239,266,realized in response to stimulus,virus
obo:RO_0004026,obo:UBERON_0002107,265,disease has location,liver
obo:RO_0004026,obo:UBERON_0000965,264,disease has location,lens of camera-type eye
obo:RO_0004026,obo:UBERON_0001637,261,disease has location,artery
obo:RO_0004021,obo:GO_0002250,258,disease caused by disruption of,adaptive immune response
obo:RO_0004021,obo:GO_0002250,258,disease has basis in disruption of,adaptive immune response
obo:RO_0004030,obo:CL_0000586,253,disease arises from structure,germ cell
obo:RO_0004029,obo:HP_0001251,252,disease has feature,Ataxia
obo:RO_0004020,obo:UBERON_0002037,251,disease has basis in dysfunction of,cerebellum
mondo:disease_has_major_feature,obo:HP_0001251,249,disease has major feature,Ataxia
obo:RO_0004024,obo:GO_0007596,241,disease disrupts,blood coagulation
obo:RO_0004024,obo:GO_0007596,241,disease causes disruption of,blood coagulation
obo:RO_0004021,obo:GO_0014032,240,disease caused by disruption of,neural crest cell development
obo:RO_0004021,obo:GO_0014032,240,disease has basis in disruption of,neural crest cell development
obo:RO_0004026,obo:UBERON_0001264,238,disease has location,pancreas
obo:RO_0004026,obo:UBERON_0000995,235,disease has location,uterus
obo:RO_0004026,obo:UBERON_0000992,232,disease has location,ovary
obo:RO_0004026,obo:UBERON_0000992,232,disease has location,female gonad
obo:RO_0004021,obo:GO_0007507,230,disease caused by disruption of,heart development
obo:RO_0004021,obo:GO_0007507,230,disease has basis in disruption of,heart development
obo:RO_0004026,obo:UBERON_0000059,227,disease has location,large intestine
obo:RO_0004030,obo:UBERON_0034705,224,disease arises from structure,developing neuroepithelium
obo:RO_0004026,obo:UBERON_0036302,224,disease has location,vasculature of central nervous system plus retina
obo:RO_0002573,obo:PATO_0000389,221,has modifier,acute
obo:RO_0004024,obo:GO_0006119,216,disease disrupts,oxidative phosphorylation
obo:RO_0004024,obo:GO_0006119,216,disease causes disruption of,oxidative phosphorylation
obo:RO_0002573,obo:PATO_0001863,216,has modifier,chronic
obo:RO_0004020,obo:GO_0032991,214,disease has basis in dysfunction of,protein-containing complex
obo:RO_0004021,obo:GO_0045087,206,disease caused by disruption of,innate immune response
obo:RO_0004021,obo:GO_0045087,206,disease has basis in disruption of,innate immune response
mondo:disease_has_major_feature,obo:HP_0007754,206,disease has major feature,Macular dystrophy
obo:RO_0004026,obo:UBERON_0002465,205,disease has location,lymphoid system
obo:RO_0004024,obo:GO_0003824,204,disease disrupts,catalytic activity
obo:RO_0004024,obo:GO_0003824,204,disease causes disruption of,catalytic activity
obo:RO_0004026,obo:UBERON_0000074,204,disease has location,renal glomerulus
obo:RO_0004026,obo:UBERON_0034713,204,disease has location,cranial neuron projection bundle
obo:RO_0002573,obo:MONDO_0045036,203,has modifier,primary infectious
mondo:disease_has_basis_in_development_of,obo:UBERON_0000924,201,disease_has_basis_in_development_of,ectoderm
obo:RO_0004021,obo:GO_0002376,196,disease caused by disruption of,immune system process
obo:RO_0004021,obo:GO_0002376,196,disease has basis in disruption of,immune system process
obo:RO_0004026,obo:UBERON_0000310,196,disease has location,breast
obo:RO_0004026,obo:UBERON_0002067,196,disease has location,dermis
obo:RO_0004021,obo:GO_0006520,193,disease caused by disruption of,cellular amino acid metabolic process
obo:RO_0004021,obo:GO_0006520,193,disease has basis in disruption of,cellular amino acid metabolic process
obo:RO_0004021,obo:GO_0070085,193,disease caused by disruption of,glycosylation
obo:RO_0004021,obo:GO_0070085,193,disease has basis in disruption of,glycosylation
obo:RO_0004026,obo:UBERON_0000964,193,disease has location,cornea
obo:RO_0004026,obo:UBERON_0004765,192,disease has location,skeletal element
obo:RO_0004026,obo:UBERON_0006558,190,disease has location,lymphatic part of lymphoid system
obo:RO_0004026,obo:UBERON_0003672,189,disease has location,dentition
obo:RO_0004027,obo:UBERON_0000014,186,disease has inflammation site,zone of skin
obo:RO_0004026,obo:UBERON_0001981,182,disease has location,blood vessel
obo:RO_0004026,obo:UBERON_0002371,180,disease has location,bone marrow
obo:RO_0004030,obo:UBERON_0004638,178,disease arises from structure,blood vessel endothelium
obo:RO_0004026,obo:UBERON_0005409,171,disease has location,alimentary part of gastrointestinal system
obo:RO_0004026,obo:UBERON_0011932,171,disease has location,pilosebaceous unit
obo:RO_0004026,obo:UBERON_0012652,171,disease has location,colorectum
obo:RO_0004026,obo:UBERON_0003129,169,disease has location,skull
obo:RO_0004026,obo:CL_0000236,167,disease has location,B cell
obo:RO_0004022,obo:MONDO_0005550,167,disease arises from feature,infectious disease
obo:RO_0004022,obo:MONDO_0005550,167,disease has basis in feature,infectious disease
obo:RO_0004020,obo:UBERON_0009773,167,disease has basis in dysfunction of,renal tubule
obo:RO_0004020,obo:GO_0005764,165,disease has basis in dysfunction of,lysosome
obo:RO_0004026,obo:UBERON_0000016,165,disease has location,endocrine pancreas
obo:RO_0004029,obo:HP_0004348,161,disease has feature,Abnormality of bone mineral density
obo:RO_0004024,obo:GO_0005215,160,disease disrupts,transporter activity
obo:RO_0004024,obo:GO_0005215,160,disease causes disruption of,transporter activity
obo:RO_0004024,obo:GO_0033059,159,disease disrupts,cellular pigmentation
obo:RO_0004024,obo:GO_0033059,159,disease causes disruption of,cellular pigmentation
obo:RO_0004026,obo:UBERON_0002369,159,disease has location,adrenal gland
obo:RO_0004030,obo:CL_0000076,158,disease arises from structure,squamous epithelial cell
obo:RO_0004026,obo:UBERON_0002240,158,disease has location,spinal cord
obo:RO_0004026,obo:UBERON_0001173,157,disease has location,biliary tree
obo:RO_0004026,obo:UBERON_0002046,157,disease has location,thyroid gland
obo:RO_0004020,obo:GO_0005929,156,disease has basis in dysfunction of,cilium
obo:RO_0004026,obo:UBERON_0002027,156,disease has location,stratum corneum of epidermis
obo:RO_0004026,obo:UBERON_0009773,153,disease has location,renal tubule
obo:RO_0004026,obo:UBERON_0003135,150,disease has location,male reproductive organ
obo:RO_0004024,obo:GO_0006006,147,disease disrupts,glucose metabolic process
obo:RO_0004024,obo:GO_0006006,147,disease causes disruption of,glucose metabolic process
obo:RO_0004026,obo:UBERON_0001091,143,disease has location,calcareous tooth
obo:RO_0004026,obo:UBERON_0002530,143,disease has location,gland
obo:RO_0004029,obo:MONDO_0005027,142,disease has feature,epilepsy
obo:RO_0004021,obo:GO_0005216,141,disease caused by disruption of,ion channel activity
obo:RO_0004021,obo:GO_0005216,141,disease has basis in disruption of,ion channel activity
obo:RO_0004026,obo:UBERON_0001557,139,disease has location,upper respiratory tract
obo:RO_0004024,obo:GO_0031424,138,disease disrupts,keratinization
obo:RO_0004024,obo:GO_0031424,138,disease causes disruption of,keratinization
obo:RO_0004026,obo:CL_0000100,134,disease has location,motor neuron
obo:RO_0004026,obo:UBERON_0010133,133,disease has location,neuroendocrine gland
obo:RO_0004030,obo:CL_0000125,132,disease arises from structure,glial cell
obo:RO_0004021,obo:GO_0007548,132,disease caused by disruption of,sex differentiation
obo:RO_0004021,obo:GO_0007548,132,disease has basis in disruption of,sex differentiation
obo:RO_0004026,obo:UBERON_0001768,132,disease has location,uvea
obo:RO_0004026,obo:UBERON_0001811,130,disease has location,conjunctiva
obo:RO_0004030,obo:CL_0000148,129,disease arises from structure,melanocyte
obo:RO_0004027,obo:UBERON_0001017,129,disease has inflammation site,central nervous system
obo:RO_0004026,obo:UBERON_0002074,129,disease has location,hair shaft
obo:RO_0004026,obo:UBERON_0002394,129,disease has location,bile duct
obo:RO_0004022,obo:MONDO_0005108,128,disease arises from feature,viral infectious disease
obo:RO_0004022,obo:MONDO_0005108,128,disease has basis in feature,viral infectious disease
mondo:disease_has_major_feature,obo:HP_0003429,126,disease has major feature,CNS hypomyelination
obo:RO_0004026,obo:UBERON_0002101,126,disease has location,limb
obo:RO_0004029,obo:HP_0012735,124,disease has feature,Cough
obo:RO_0004026,obo:UBERON_0001032,123,disease has location,sensory system
obo:RO_0004026,obo:UBERON_0002203,123,disease has location,vasculature of eye
obo:RO_0004029,obo:HP_0002321,122,disease has feature,Vertigo
obo:RO_0002573,obo:MONDO_0024495,121,has modifier,"tumor grade 1 or 2, general grading system"
obo:RO_0004026,obo:UBERON_0001690,121,disease has location,ear
obo:RO_0004022,obo:MONDO_0005559,120,disease arises from feature,neurodegenerative disease
obo:RO_0004022,obo:MONDO_0005559,120,disease has basis in feature,neurodegenerative disease
obo:RO_0002573,obo:MONDO_0024497,119,has modifier,"tumor grade 3 or 4, general grading system"
obo:RO_0004029,obo:MONDO_0002280,118,disease has feature,anemia (disease)
obo:RO_0004029,obo:HP_0000496,115,disease has feature,Abnormality of eye movement
obo:RO_0004029,obo:HP_0000508,115,disease has feature,Ptosis
obo:RO_0004021,obo:GO_0009100,114,disease caused by disruption of,glycoprotein metabolic process
obo:RO_0004021,obo:GO_0009100,114,disease has basis in disruption of,glycoprotein metabolic process
obo:RO_0004026,obo:UBERON_0001155,114,disease has location,colon
obo:RO_0004022,obo:HP_0000822,113,disease arises from feature,Hypertension
obo:RO_0004022,obo:HP_0000822,113,disease has basis in feature,Hypertension
obo:RO_0004029,obo:HP_0001257,113,disease has feature,Spasticity
obo:RO_0004029,obo:HP_0010550,113,disease has feature,Paraplegia
obo:RO_0004020,obo:CL_0000233,112,disease has basis in dysfunction of,platelet
mondo:disease_has_major_feature,obo:HP_0001156,112,disease has major feature,Brachydactyly
obo:RO_0004029,obo:HP_0001156,112,disease has feature,Brachydactyly
obo:RO_0004026,obo:UBERON_0004573,112,disease has location,systemic artery
obo:RO_0004030,obo:UBERON_0012429,111,disease arises from structure,hematopoietic tissue
obo:RO_0004024,obo:GO_0003015,110,disease disrupts,heart process
obo:RO_0004024,obo:GO_0003015,110,disease causes disruption of,heart process
obo:RO_0004026,obo:UBERON_0000945,109,disease has location,stomach
obo:RO_0004026,obo:UBERON_0000007,108,disease has location,pituitary gland
mondo:disease_causes_feature,obo:HP_0003074,107,disease causes feature,Hyperglycemia
obo:RO_0004029,obo:HP_0004322,107,disease has feature,Short stature
obo:RO_0004026,obo:UBERON_0001555,106,disease has location,digestive tract
obo:RO_0004021,obo:GO_0016068,104,disease caused by disruption of,type I hypersensitivity
obo:RO_0004021,obo:GO_0016068,104,disease has basis in disruption of,type I hypersensitivity
obo:RO_0004026,obo:UBERON_0001255,104,disease has location,urinary bladder
obo:RO_0004026,obo:UBERON_0002108,104,disease has location,small intestine
obo:RO_0004026,obo:UBERON_0000982,103,disease has location,skeletal joint
obo:RO_0009501,obo:ECTO_0000231,101,realized in response to,exposure to chemical entity
obo:RO_0004021,obo:GO_0005183,101,disease caused by disruption of,gonadotropin hormone-releasing hormone activity
obo:RO_0004021,obo:GO_0005183,101,disease has basis in disruption of,gonadotropin hormone-releasing hormone activity
obo:RO_0004029,obo:HP_0000486,101,disease has feature,Strabismus
obo:RO_0004030,obo:CL_0000236,100,disease arises from structure,B cell
obo:RO_0004021,obo:GO_0006954,100,disease caused by disruption of,inflammatory response
obo:RO_0004021,obo:GO_0006954,100,disease has basis in disruption of,inflammatory response
obo:RO_0004020,obo:GO_0061702,100,disease has basis in dysfunction of,inflammasome complex
obo:RO_0004022,obo:MONDO_0024237,99,disease arises from feature,inherited neurodegenerative disorder
obo:RO_0004022,obo:MONDO_0024237,99,disease has basis in feature,inherited neurodegenerative disorder
obo:RO_0004030,obo:CL_0000187,98,disease arises from structure,muscle cell
obo:RO_0004029,obo:HP_0002013,98,disease has feature,Vomiting
obo:RO_0004029,obo:MONDO_0005129,97,disease has feature,cataract (disease)
obo:RO_0004026,obo:UBERON_0010743,97,disease has location,meningeal cluster
obo:RO_0002573,obo:HP_0003593,96,has modifier,Infantile onset
obo:RO_0004028,obo:NCBITaxon_4751,95,realized in response to stimulus,Fungi
obo:RO_0004026,obo:UBERON_0001750,95,disease has location,lacrimal apparatus
obo:RO_0004026,obo:UBERON_0002257,95,disease has location,ventral horn of spinal cord
obo:RO_0004025,obo:UBERON_0002521,95,disease causes dysfunction of,elastic tissue
obo:RO_0004030,obo:CL_0000192,94,disease arises from structure,smooth muscle cell
obo:RO_0004024,obo:GO_0046849,94,disease disrupts,bone remodeling
obo:RO_0004024,obo:GO_0046849,94,disease causes disruption of,bone remodeling
mondo:disease_has_major_feature,obo:HP_0000501,94,disease has major feature,Glaucoma
obo:RO_0004030,obo:CL_0000071,93,disease arises from structure,blood vessel endothelial cell
obo:RO_0004029,obo:HP_0001513,93,disease has feature,Obesity
obo:RO_0004021,obo:GO_0007565,89,disease caused by disruption of,female pregnancy
obo:RO_0004021,obo:GO_0007565,89,disease has basis in disruption of,female pregnancy
obo:RO_0004024,obo:GO_0016042,89,disease disrupts,lipid catabolic process
obo:RO_0004024,obo:GO_0016042,89,disease causes disruption of,lipid catabolic process
obo:RO_0004021,obo:GO_0019915,89,disease caused by disruption of,lipid storage
obo:RO_0004021,obo:GO_0019915,89,disease has basis in disruption of,lipid storage
obo:RO_0004026,obo:UBERON_0009097,89,disease has location,gravid organism
obo:RO_0004026,obo:UBERON_0001132,87,disease has location,parathyroid gland
obo:RO_0004026,obo:CL_0000057,86,disease has location,fibroblast
obo:RO_0004030,obo:CL_0000057,86,disease arises from structure,fibroblast
obo:RO_0004024,obo:GO_0007165,86,disease disrupts,signal transduction
obo:RO_0004024,obo:GO_0007165,86,disease causes disruption of,signal transduction
obo:RO_0004026,obo:UBERON_0000004,86,disease has location,nose
obo:RO_0004026,obo:UBERON_0000002,85,disease has location,uterine cervix
obo:RO_0004026,obo:UBERON_0001013,83,disease has location,adipose tissue
obo:RO_0004026,obo:UBERON_0002517,83,disease has location,basicranium
obo:RO_0004026,obo:UBERON_0004908,83,disease has location,upper digestive tract
obo:RO_0004029,obo:HP_0008066,82,disease has feature,Abnormal blistering of the skin
obo:RO_0004026,obo:UBERON_0008998,82,disease has location,vasculature of brain
obo:RO_0004021,obo:GO_0006493,81,disease caused by disruption of,protein O-linked glycosylation
obo:RO_0004021,obo:GO_0006493,81,disease has basis in disruption of,protein O-linked glycosylation
obo:RO_0004029,obo:HP_0030828,81,disease has feature,Wheezing
obo:BFO_0000054,obo:NCIT_C19085,81,realized in,Sexual Transmission
obo:RO_0004026,obo:UBERON_0001043,81,disease has location,esophagus
obo:RO_0004026,obo:UBERON_0001052,81,disease has location,rectum
mondo:disease_has_major_feature,obo:HP_0000953,80,disease has major feature,Hyperpigmentation of the skin
obo:RO_0002573,obo:HP_0003581,80,has modifier,Adult onset
obo:RO_0004029,obo:HP_0001824,79,disease has feature,Weight loss
obo:RO_0004026,obo:UBERON_0000473,79,disease has location,testis
obo:RO_0004026,obo:UBERON_0001897,79,disease has location,dorsal plus ventral thalamus
obo:RO_0004027,obo:UBERON_0000955,78,disease has inflammation site,brain
obo:RO_0004026,obo:UBERON_0005090,78,disease has location,muscle structure
obo:RO_0004021,obo:GO_0006281,76,disease caused by disruption of,DNA repair
obo:RO_0004021,obo:GO_0006281,76,disease has basis in disruption of,DNA repair
obo:RO_0004024,obo:GO_0007601,76,disease disrupts,visual perception
obo:RO_0004024,obo:GO_0007601,76,disease causes disruption of,visual perception
obo:RO_0004030,obo:CL_0000785,75,disease arises from structure,mature B cell
obo:RO_0004021,obo:GO_0060235,75,disease caused by disruption of,lens induction in camera-type eye
obo:RO_0004021,obo:GO_0060235,75,disease has basis in disruption of,lens induction in camera-type eye
obo:RO_0004029,obo:HP_0000107,75,disease has feature,Renal cyst
obo:RO_0004029,obo:HP_0011001,74,disease has feature,Increased bone mineral density
obo:RO_0004026,obo:UBERON_0000997,74,disease has location,mammalian vulva
obo:RO_0004026,obo:UBERON_0000946,73,disease has location,cardial valve
obo:RO_0004027,obo:UBERON_0002049,73,disease has inflammation site,vasculature
obo:RO_0004029,obo:HP_0002829,72,disease has feature,Arthralgia
obo:RO_0002573,obo:PATO_0001673,72,has modifier,cystic
obo:RO_0004026,obo:UBERON_0001474,72,disease has location,bone element
obo:RO_0004026,obo:UBERON_0000167,71,disease has location,oral cavity
obo:RO_0004026,obo:CL_0000232,70,disease has location,erythrocyte
obo:RO_0004029,obo:HP_0001548,69,disease has feature,Overgrowth
obo:RO_0004020,obo:CL_0000234,68,disease has basis in dysfunction of,phagocyte
obo:RO_0004030,obo:CL_0002576,68,disease arises from structure,perineural cell
obo:RO_0004024,obo:GO_0006909,68,disease disrupts,phagocytosis
obo:RO_0004024,obo:GO_0006909,68,disease causes disruption of,phagocytosis
obo:RO_0004029,obo:HP_0001324,68,disease has feature,Muscle weakness
obo:RO_0004029,obo:HP_0002315,68,disease has feature,Headache
obo:RO_0004021,obo:GO_0008202,67,disease caused by disruption of,steroid metabolic process
obo:RO_0004021,obo:GO_0008202,67,disease has basis in disruption of,steroid metabolic process
obo:RO_0004026,obo:UBERON_0001820,67,disease has location,sweat gland
obo:RO_0002573,obo:SO_1000029,66,has modifier,chromosomal_deletion
obo:RO_0004026,obo:UBERON_0002367,66,disease has location,prostate gland
obo:RO_0004026,obo:UBERON_0010011,64,disease has location,collection of basal ganglia
obo:RO_0004029,obo:HP_0002503,63,disease has feature,Spinocerebellar tract degeneration
obo:RO_0004029,obo:MONDO_0100035,63,disease has feature,structural epilepsy
obo:RO_0004029,obo:HP_0001903,62,disease has feature,Anemia
obo:RO_0004029,obo:HP_0004349,62,disease has feature,Reduced bone mineral density
obo:RO_0002573,obo:MONDO_0024493,62,has modifier,"tumor grade 3, general grading system"
obo:RO_0002573,obo:PATO_0002132,62,has modifier,"neoplastic, non-invasive"
obo:RO_0004026,obo:UBERON_0001042,62,disease has location,chordate pharynx
obo:RO_0004028,obo:NCBITaxon_1763,61,realized in response to stimulus,Mycobacterium
obo:RO_0004026,obo:UBERON_0001044,60,disease has location,saliva-secreting gland
obo:RO_0004024,obo:GO_0007568,59,disease disrupts,aging
obo:RO_0004024,obo:GO_0007568,59,disease causes disruption of,aging
mondo:disease_has_major_feature,obo:HP_0000252,59,disease has major feature,Microcephaly
obo:RO_0004029,obo:HP_0000528,59,disease has feature,Anophthalmia
obo:RO_0004029,obo:HP_0000568,59,disease has feature,Microphthalmia
mondo:disease_has_major_feature,obo:HP_0001010,59,disease has major feature,Hypopigmentation of the skin
mondo:disease_has_major_feature,obo:HP_0001669,59,disease has major feature,Transposition of the great arteries
mondo:disease_has_major_feature,obo:HP_0001710,59,disease has major feature,Conotruncal defect
obo:RO_0004030,obo:UBERON_0001304,59,disease arises from structure,germinal epithelium of ovary
obo:RO_0004026,obo:UBERON_0001737,59,disease has location,larynx
obo:RO_0004026,obo:UBERON_0001893,59,disease has location,telencephalon
obo:RO_0004020,obo:CHEBI_35143,58,disease has basis in dysfunction of,hemoglobin
mondo:disease_has_major_feature,obo:HP_0001339,58,disease has major feature,Lissencephaly
obo:RO_0004026,obo:UBERON_0001825,58,disease has location,paranasal sinus
obo:RO_0004026,obo:UBERON_0002199,58,disease has location,integument
obo:RO_0004020,obo:GO_0045202,57,disease has basis in dysfunction of,synapse
obo:RO_0004026,obo:UBERON_0002349,57,disease has location,myocardium
obo:RO_0004020,obo:GO_0031594,56,disease has basis in dysfunction of,neuromuscular junction
obo:RO_0004022,obo:HP_0000044,56,disease arises from feature,Hypogonadotrophic hypogonadism
obo:RO_0004022,obo:HP_0000044,56,disease has basis in feature,Hypogonadotrophic hypogonadism
obo:RO_0004026,obo:UBERON_0002097,56,disease has location,skin of body
obo:RO_0004026,obo:UBERON_0011156,56,disease has location,facial skeleton
obo:RO_0004021,obo:GO_0005777,55,disease caused by disruption of,peroxisome
obo:RO_0004021,obo:GO_0005777,55,disease has basis in disruption of,peroxisome
obo:RO_0004021,obo:GO_0006790,55,disease caused by disruption of,sulfur compound metabolic process
obo:RO_0004021,obo:GO_0006790,55,disease has basis in disruption of,sulfur compound metabolic process
obo:RO_0004029,obo:HP_0002105,55,disease has feature,Hemoptysis
mondo:disease_has_major_feature,obo:HP_0007773,55,disease has major feature,Vitreoretinopathy
obo:RO_0004029,obo:HP_0010442,55,disease has feature,Polydactyly
obo:RO_0004026,obo:UBERON_0001135,55,disease has location,smooth muscle tissue
obo:RO_0004026,obo:UBERON_0001898,55,disease has location,hypothalamus
obo:RO_0004029,obo:MONDO_0002516,54,disease has feature,digestive system cancer
obo:RO_0004029,obo:MONDO_0005093,54,disease has feature,skin disease
obo:RO_0004026,obo:UBERON_0000020,54,disease has location,sense organ
obo:RO_0004026,obo:UBERON_0035549,54,disease has location,vasculature of integument
obo:RO_0004021,obo:GO_0006665,53,disease caused by disruption of,sphingolipid metabolic process
obo:RO_0004021,obo:GO_0006665,53,disease has basis in disruption of,sphingolipid metabolic process
obo:RO_0004029,obo:MONDO_0005045,53,disease has feature,hypertrophic cardiomyopathy
obo:RO_0004027,obo:UBERON_0000982,53,disease has inflammation site,skeletal joint
obo:RO_0004026,obo:UBERON_0001705,53,disease has location,nail
obo:RO_0004026,obo:UBERON_0006562,53,disease has location,pharynx
obo:RO_0004021,obo:GO_0032543,52,disease caused by disruption of,mitochondrial translation
obo:RO_0004021,obo:GO_0032543,52,disease has basis in disruption of,mitochondrial translation
mondo:disease_has_major_feature,obo:HP_0010442,52,disease has major feature,Polydactyly
obo:RO_0004026,obo:UBERON_0000941,52,disease has location,cranial nerve II
obo:RO_0004026,obo:UBERON_0001295,52,disease has location,endometrium
obo:RO_0004026,obo:UBERON_0003703,52,disease has location,extrahepatic bile duct
obo:RO_0004026,obo:UBERON_0010366,52,disease has location,conjunctival vasculature
obo:RO_0004021,obo:GO_0006778,51,disease caused by disruption of,porphyrin-containing compound metabolic process
obo:RO_0004021,obo:GO_0006778,51,disease has basis in disruption of,porphyrin-containing compound metabolic process
obo:RO_0004021,obo:GO_0120054,51,disease caused by disruption of,intestinal motility
obo:RO_0004021,obo:GO_0120054,51,disease has basis in disruption of,intestinal motility
obo:RO_0002573,obo:MONDO_0024491,51,has modifier,"tumor grade 1, general grading system"
obo:RO_0004026,obo:UBERON_0000947,51,disease has location,aorta
obo:RO_0004026,obo:UBERON_0000996,51,disease has location,vagina
obo:RO_0004030,obo:CL_0000542,50,disease arises from structure,lymphocyte
obo:RO_0004024,obo:GO_0010259,50,disease disrupts,multicellular organism aging
obo:RO_0004024,obo:GO_0010259,50,disease causes disruption of,multicellular organism aging
mondo:disease_has_major_feature,obo:HP_0002459,50,disease has major feature,obsolete Dysautonomia
mondo:disease_has_major_feature,obo:HP_0002459,50,disease has major feature,Dysautonomia
obo:RO_0002573,obo:PATO_0002129,50,has modifier,"neoplastic, invasive"
obo:RO_0004027,obo:UBERON_0001768,50,disease has inflammation site,uvea
obo:RO_0004026,obo:UBERON_0002410,50,disease has location,autonomic nervous system
obo:RO_0004030,obo:UBERON_0006799,50,disease arises from structure,glandular epithelium
obo:RO_0004026,obo:UBERON_0009853,50,disease has location,body of uterus
obo:RO_0004021,obo:GO_0030317,49,disease caused by disruption of,flagellated sperm motility
obo:RO_0004021,obo:GO_0030317,49,disease has basis in disruption of,flagellated sperm motility
obo:RO_0004024,obo:GO_0030431,49,disease disrupts,sleep
obo:RO_0004024,obo:GO_0030431,49,disease causes disruption of,sleep
mondo:disease_causes_feature,obo:MONDO_0001106,49,disease causes feature,kidney failure
obo:RO_0004026,obo:UBERON_0000365,49,disease has location,urothelium
obo:RO_0004026,obo:UBERON_0001756,49,disease has location,middle ear
obo:RO_0004027,obo:UBERON_0002113,49,disease has inflammation site,kidney
obo:RO_0004026,obo:UBERON_0011818,49,disease has location,superficial fascia
obo:RO_0004021,obo:GO_0070293,48,disease caused by disruption of,renal absorption
obo:RO_0004021,obo:GO_0070293,48,disease has basis in disruption of,renal absorption
obo:RO_0004026,obo:UBERON_0001643,48,disease has location,oculomotor nerve
obo:RO_0004026,obo:UBERON_0001769,48,disease has location,iris
obo:RO_0004026,obo:UBERON_0002012,48,disease has location,pulmonary artery
obo:RO_0004030,obo:CL_0000731,47,disease arises from structure,urothelial cell
obo:RO_0004021,obo:GO_0003824,47,disease caused by disruption of,catalytic activity
obo:RO_0004021,obo:GO_0003824,47,disease has basis in disruption of,catalytic activity
obo:RO_0004021,obo:GO_0008015,47,disease caused by disruption of,blood circulation
obo:RO_0004021,obo:GO_0008015,47,disease has basis in disruption of,blood circulation
obo:RO_0004022,obo:MONDO_0004580,47,disease arises from feature,retinal degeneration
obo:RO_0004022,obo:MONDO_0004580,47,disease has basis in feature,retinal degeneration
obo:RO_0004026,obo:UBERON_0000053,47,disease has location,macula lutea
obo:RO_0004026,obo:UBERON_0002110,47,disease has location,gall bladder
obo:RO_0004024,obo:GO_0061337,46,disease disrupts,cardiac conduction
obo:RO_0004024,obo:GO_0061337,46,disease causes disruption of,cardiac conduction
obo:RO_0004020,obo:PR_000006537,46,disease has basis in dysfunction of,dystrophin
obo:RO_0004030,obo:UBERON_0000365,46,disease arises from structure,urothelium
obo:RO_0004026,obo:UBERON_0000974,46,disease has location,neck
obo:RO_0004026,obo:UBERON_0003729,46,disease has location,mouth mucosa
obo:RO_0004021,obo:GO_0000002,45,disease caused by disruption of,mitochondrial genome maintenance
obo:RO_0004021,obo:GO_0000002,45,disease has basis in disruption of,mitochondrial genome maintenance
obo:RO_0004021,obo:GO_0005977,45,disease caused by disruption of,glycogen metabolic process
obo:RO_0004021,obo:GO_0005977,45,disease has basis in disruption of,glycogen metabolic process
obo:RO_0004021,obo:GO_0006144,45,disease caused by disruption of,purine nucleobase metabolic process
obo:RO_0004021,obo:GO_0006144,45,disease has basis in disruption of,purine nucleobase metabolic process
obo:RO_0004029,obo:HP_0002789,45,disease has feature,Tachypnea
obo:RO_0004028,obo:NCBITaxon_10292,45,realized in response to stimulus,Herpesviridae
obo:RO_0004026,obo:UBERON_0000017,45,disease has location,exocrine pancreas
obo:RO_0004026,obo:UBERON_0001846,45,disease has location,internal ear
obo:RO_0004030,obo:UBERON_0002346,45,disease arises from structure,neurectoderm
obo:RO_0004026,obo:UBERON_0003889,45,disease has location,fallopian tube
obo:RO_0004026,obo:UBERON_0001911,44,disease has location,mammary gland
obo:RO_0004020,obo:GO_0005581,43,disease has basis in dysfunction of,collagen trimer
obo:RO_0004024,obo:GO_0006486,43,disease disrupts,protein glycosylation
obo:RO_0004024,obo:GO_0006486,43,disease causes disruption of,protein glycosylation
mondo:disease_has_major_feature,obo:HP_0006705,43,disease has major feature,Abnormal atrioventricular valve morphology
obo:RO_0004028,obo:NCBITaxon_1773,43,realized in response to stimulus,Mycobacterium tuberculosis
obo:RO_0004020,obo:PR_000015322,43,disease has basis in dysfunction of,alpha-synuclein
obo:RO_0004026,obo:UBERON_0001245,43,disease has location,anus
obo:RO_0004026,obo:UBERON_0002133,43,disease has location,atrioventricular valve
obo:RO_0004022,obo:HP_0000133,42,disease arises from feature,Gonadal dysgenesis
obo:RO_0004022,obo:HP_0000133,42,disease has basis in feature,Gonadal dysgenesis
obo:RO_0004029,obo:HP_0000478,42,disease has feature,Abnormality of the eye
mondo:disease_has_major_feature,obo:HP_0000924,42,disease has major feature,Abnormality of the skeletal system
obo:RO_0004029,obo:HP_0001597,42,disease has feature,Abnormality of the nail
obo:RO_0004029,obo:HP_0001735,42,disease has feature,Acute pancreatitis
mondo:disease_has_major_feature,obo:HP_0007435,42,disease has major feature,Diffuse palmoplantar keratoderma
obo:RO_0004029,obo:MONDO_0006515,42,disease has feature,acute pancreatitis
obo:RO_0004026,obo:UBERON_0002370,42,disease has location,thymus
obo:RO_0004030,obo:CL_0000084,41,disease arises from structure,T cell
obo:RO_0002573,obo:SO_1000008,41,has modifier,point_mutation
obo:RO_0004026,obo:UBERON_0000057,41,disease has location,urethra
obo:RO_0004027,obo:UBERON_0000160,41,disease has inflammation site,intestine
obo:RO_0004030,obo:UBERON_0004801,41,disease arises from structure,cervix epithelium
obo:RO_0004026,obo:CL_0000019,40,disease has location,sperm
obo:RO_0004021,obo:GO_0001843,40,disease caused by disruption of,neural tube closure
obo:RO_0004021,obo:GO_0001843,40,disease has basis in disruption of,neural tube closure
obo:RO_0004024,obo:GO_0050892,40,disease disrupts,intestinal absorption
obo:RO_0004024,obo:GO_0050892,40,disease causes disruption of,intestinal absorption
obo:RO_0004029,obo:HP_0000093,40,disease has feature,Proteinuria
obo:RO_0004029,obo:HP_0000969,40,disease has feature,Edema
obo:RO_0004029,obo:HP_0003073,40,disease has feature,Hypoalbuminemia
obo:RO_0002573,obo:MONDO_0045035,40,has modifier,opportunistic infectious
obo:RO_0004026,obo:UBERON_0006742,40,disease has location,canthus
mondo:disease_has_major_feature,obo:HP_0000618,39,disease has major feature,Blindness
obo:RO_0004029,obo:HP_0007354,39,disease has feature,Amyotrophic lateral sclerosis
obo:RO_0004027,obo:UBERON_0000344,39,disease has inflammation site,mucosa
obo:RO_0004026,obo:UBERON_0001130,39,disease has location,vertebral column
obo:RO_0004029,obo:HP_0000099,38,disease has feature,Glomerulonephritis
mondo:disease_has_major_feature,obo:HP_0009125,38,disease has major feature,Lipodystrophy
obo:RO_0004028,obo:NCBITaxon_203691,38,realized in response to stimulus,Spirochaetes
obo:RO_0004026,obo:UBERON_0001027,38,disease has location,sensory nerve
obo:RO_0004026,obo:UBERON_0001776,38,disease has location,optic choroid
obo:RO_0004026,obo:CL_0000244,37,disease has location,transitional epithelial cell
obo:RO_0004024,obo:GO_0006631,37,disease disrupts,fatty acid metabolic process
obo:RO_0004024,obo:GO_0006631,37,disease causes disruption of,fatty acid metabolic process
obo:RO_0004029,obo:MONDO_0005872,37,disease has feature,nervous system cancer
obo:RO_0004028,obo:NCBITaxon_766,37,realized in response to stimulus,Rickettsiales
obo:RO_0004026,obo:UBERON_0001758,37,disease has location,periodontium
obo:RO_0004026,obo:UBERON_0003728,37,disease has location,mediastinum
obo:RO_0004028,obo:FOODON_00002403,36,realized in response to stimulus,food material
obo:RO_0004021,obo:GO_0016125,36,disease caused by disruption of,sterol metabolic process
obo:RO_0004021,obo:GO_0016125,36,disease has basis in disruption of,sterol metabolic process
obo:RO_0004028,obo:NCBITaxon_6231,36,realized in response to stimulus,Nematoda
obo:RO_0002573,obo:PATO_0002092,36,has modifier,anaplastic
obo:RO_0004026,obo:UBERON_0000056,36,disease has location,ureter
obo:RO_0004027,obo:UBERON_0000964,36,disease has inflammation site,cornea
obo:RO_0004026,obo:UBERON_0000989,36,disease has location,penis
obo:RO_0004030,obo:CL_0000669,35,disease arises from structure,pericyte cell
obo:RO_0004021,obo:GO_0006956,35,disease caused by disruption of,complement activation
obo:RO_0004021,obo:GO_0006956,35,disease has basis in disruption of,complement activation
obo:RO_0004029,obo:HP_0003473,35,disease has feature,Fatigable weakness
obo:RO_0004029,obo:MONDO_0018398,35,disease has feature,female infertility due to a congenital hypogonadotropic hypogonadism
obo:RO_0002573,obo:MONDO_0022202,35,has modifier,disseminated
obo:RO_0004027,obo:UBERON_0001811,35,disease has inflammation site,conjunctiva
obo:RO_0004021,obo:GO_0001755,34,disease caused by disruption of,neural crest cell migration
obo:RO_0004021,obo:GO_0001755,34,disease has basis in disruption of,neural crest cell migration
obo:RO_0004021,obo:GO_0007265,34,disease caused by disruption of,Ras protein signal transduction
obo:RO_0004021,obo:GO_0007265,34,disease has basis in disruption of,Ras protein signal transduction
obo:RO_0004026,obo:UBERON_0000383,34,disease has location,musculature of body
obo:RO_0004030,obo:UBERON_0000924,34,disease arises from structure,ectoderm
obo:RO_0004026,obo:UBERON_0001153,34,disease has location,caecum
obo:RO_0004026,obo:UBERON_0002114,34,disease has location,duodenum
obo:RO_0004027,obo:UBERON_0002385,34,disease has inflammation site,muscle tissue
obo:RO_0004021,obo:GO_0006766,33,disease caused by disruption of,vitamin metabolic process
obo:RO_0004021,obo:GO_0006766,33,disease has basis in disruption of,vitamin metabolic process
obo:RO_0004024,obo:GO_0008015,33,disease disrupts,blood circulation
obo:RO_0004024,obo:GO_0008015,33,disease causes disruption of,blood circulation
obo:RO_0004029,obo:HP_0002145,33,disease has feature,Frontotemporal dementia
obo:RO_0002573,obo:MONDO_0024492,33,has modifier,"tumor grade 2, general grading system"
obo:RO_0004026,obo:UBERON_0001797,33,disease has location,vitreous humor
obo:RO_0004026,obo:UBERON_0003499,33,disease has location,brain blood vessel
obo:RO_0004030,obo:CL_0000646,32,disease arises from structure,basal cell
obo:RO_0009501,obo:ECTO_0000509,32,realized in response to,exposure to drug
mondo:disease_has_major_feature,obo:HP_0000951,32,disease has major feature,Abnormality of the skin
obo:RO_0004029,obo:HP_0000988,32,disease has feature,Skin rash
mondo:disease_has_major_feature,obo:HP_0002315,32,disease has major feature,Headache
obo:RO_0002573,obo:MONDO_0045042,32,has modifier,localized
obo:RO_0004026,obo:UBERON_0001638,32,disease has location,vein
obo:RO_0004030,obo:UBERON_0002384,32,disease arises from structure,connective tissue
obo:RO_0004026,obo:UBERON_0003126,32,disease has location,trachea
obo:RO_0004026,obo:UBERON_0004864,32,disease has location,vasculature of retina
obo:RO_0004021,obo:GO_0006487,31,disease caused by disruption of,protein N-linked glycosylation
obo:RO_0004021,obo:GO_0006487,31,disease has basis in disruption of,protein N-linked glycosylation
obo:RO_0002573,obo:HP_0003623,31,has modifier,Neonatal onset
obo:RO_0004029,obo:MONDO_0019833,31,disease has feature,pituitary hormone deficiency from tumoral origin
obo:RO_0004026,obo:CL_0000127,30,disease has location,astrocyte
obo:RO_0004020,obo:GO_0005652,30,disease has basis in dysfunction of,nuclear lamina
obo:RO_0004024,obo:GO_0038023,30,disease disrupts,signaling receptor activity
obo:RO_0004024,obo:GO_0038023,30,disease causes disruption of,signaling receptor activity
mondo:disease_has_major_feature,obo:HP_0000271,30,disease has major feature,Abnormality of the face
mondo:disease_has_major_feature,obo:HP_0010524,30,disease has major feature,Agnosia
obo:RO_0002573,obo:HP_0025153,30,has modifier,Transient
obo:RO_0004024,obo:NBO_0000551,30,disease disrupts,visual object recognition
obo:RO_0004024,obo:NBO_0000551,30,disease causes disruption of,visual object recognition
obo:RO_0004028,obo:NCBITaxon_157,30,realized in response to stimulus,Treponema
obo:RO_0004029,obo:HP_0002716,29,disease has feature,Lymphadenopathy
obo:RO_0004029,obo:HP_0006530,29,disease has feature,Interstitial pulmonary abnormality
mondo:disease_has_major_feature,obo:HP_0007370,29,disease has major feature,Aplasia/Hypoplasia of the corpus callosum
obo:RO_0004029,obo:HP_0011675,29,disease has feature,Arrhythmia
obo:RO_0004022,obo:HP_0011962,29,disease arises from feature,Obstructive azoospermia
obo:RO_0004022,obo:HP_0011962,29,disease has basis in feature,Obstructive azoospermia
obo:RO_0004024,obo:MFOEM_000193,29,disease disrupts,mood process
obo:RO_0004024,obo:MFOEM_000193,29,disease causes disruption of,mood process
obo:RO_0004029,obo:MONDO_0006547,29,disease has feature,exanthem (disease)
obo:RO_0004026,obo:UBERON_0001869,29,disease has location,cerebral hemisphere
obo:RO_0004026,obo:UBERON_0005295,29,disease has location,sex cord
obo:RO_0004020,obo:CL_0000097,28,disease has basis in dysfunction of,mast cell
obo:RO_0004030,obo:CL_0011012,28,disease arises from structure,neural crest cell
obo:RO_0004024,obo:GO_0015723,28,disease disrupts,bilirubin transport
obo:RO_0004024,obo:GO_0015723,28,disease causes disruption of,bilirubin transport
obo:RO_0004024,obo:GO_0043217,28,disease disrupts,myelin maintenance
obo:RO_0004024,obo:GO_0043217,28,disease causes disruption of,myelin maintenance
obo:RO_0004029,obo:HP_0000113,28,disease has feature,Polycystic kidney dysplasia
mondo:disease_has_major_feature,obo:HP_0000202,28,disease has major feature,Oral cleft
mondo:disease_has_major_feature,obo:HP_0003077,28,disease has major feature,Hyperlipidemia
mondo:disease_has_major_feature,obo:MONDO_0005129,28,disease has major feature,cataract (disease)
obo:RO_0002573,obo:SO_1000037,28,has modifier,chromosomal_duplication
obo:RO_0004026,obo:UBERON_0000088,28,disease has location,trophoblast
obo:RO_0004027,obo:UBERON_0001756,28,disease has inflammation site,middle ear
obo:RO_0004026,obo:UBERON_0002106,28,disease has location,spleen
obo:RO_0004026,obo:UBERON_0002185,28,disease has location,bronchus
mondo:disease_has_basis_in_development_of,obo:UBERON_0012314,28,disease_has_basis_in_development_of,embryonic facial prominence
obo:RO_0004026,obo:CL_0000222,27,disease has location,mesodermal cell
obo:RO_0009501,obo:ECTO_0000259,27,realized in response to,exposure to glucocorticoid
obo:RO_0004021,obo:GO_0000096,27,disease caused by disruption of,sulfur amino acid metabolic process
obo:RO_0004021,obo:GO_0000096,27,disease has basis in disruption of,sulfur amino acid metabolic process
obo:RO_0004022,obo:HP_0001877,27,disease arises from feature,Abnormal erythrocyte morphology
obo:RO_0004022,obo:HP_0001877,27,disease has basis in feature,Abnormal erythrocyte morphology
obo:RO_0004029,obo:HP_0002090,27,disease has feature,Pneumonia
obo:RO_0004026,obo:UBERON_0000977,27,disease has location,pleura
obo:RO_0004026,obo:UBERON_0001829,27,disease has location,major salivary gland
obo:RO_0004026,obo:UBERON_0002360,27,disease has location,meninx
obo:RO_0004027,obo:UBERON_0002360,27,disease has inflammation site,meninx
obo:RO_0004026,obo:UBERON_0003693,27,disease has location,retroperitoneal space
obo:RO_0004030,obo:UBERON_0004670,27,disease arises from structure,ependyma
obo:RO_0004030,obo:CL_0000138,26,disease arises from structure,chondrocyte
obo:RO_0004030,obo:CL_0000786,26,disease arises from structure,plasma cell
obo:RO_0004024,obo:GO_0055074,26,disease disrupts,calcium ion homeostasis
obo:RO_0004024,obo:GO_0055074,26,disease causes disruption of,calcium ion homeostasis
obo:RO_0004029,obo:HP_0002185,26,disease has feature,Neurofibrillary tangles
obo:RO_0004028,obo:NCBITaxon_160,26,realized in response to stimulus,Treponema pallidum
obo:RO_0004028,obo:NCBITaxon_485,26,realized in response to stimulus,Neisseria gonorrhoeae
obo:RO_0004030,obo:UBERON_0000160,26,disease arises from structure,intestine
obo:RO_0004030,obo:UBERON_0001013,26,disease arises from structure,adipose tissue
obo:RO_0004026,obo:UBERON_0001785,26,disease has location,cranial nerve
obo:RO_0004020,obo:CL_0000169,25,disease has basis in dysfunction of,type B pancreatic cell
obo:BFO_0000054,obo:GO_0019233,25,realized in,sensory perception of pain
obo:RO_0004021,obo:GO_0035773,25,disease caused by disruption of,insulin secretion involved in cellular response to glucose stimulus
obo:RO_0004021,obo:GO_0035773,25,disease has basis in disruption of,insulin secretion involved in cellular response to glucose stimulus
obo:RO_0004021,obo:GO_1903510,25,disease caused by disruption of,mucopolysaccharide metabolic process
obo:RO_0004021,obo:GO_1903510,25,disease has basis in disruption of,mucopolysaccharide metabolic process
obo:RO_0004024,obo:GO_1990542,25,disease disrupts,mitochondrial transmembrane transport
obo:RO_0004024,obo:GO_1990542,25,disease causes disruption of,mitochondrial transmembrane transport
obo:RO_0004029,obo:HP_0000964,25,disease has feature,Eczema
obo:RO_0004029,obo:HP_0001287,25,disease has feature,Meningitis
obo:RO_0004029,obo:HP_0001369,25,disease has feature,Arthritis
obo:RO_0004022,obo:HP_0006476,25,disease arises from feature,Abnormality of the pancreatic islet cells
obo:RO_0004022,obo:HP_0006476,25,disease has basis in feature,Abnormality of the pancreatic islet cells
mondo:disease_has_major_feature,obo:HP_0012531,25,disease has major feature,Pain
obo:RO_0004029,obo:MONDO_0003778,25,disease has feature,primary immunodeficiency disease
mondo:disease_causes_feature,obo:MONDO_0012819,25,disease causes feature,diabetic ketoacidosis
obo:RO_0004028,obo:NCBITaxon_11050,25,realized in response to stimulus,Flaviviridae
obo:RO_0004028,obo:NCBITaxon_11157,25,realized in response to stimulus,Mononegavirales
obo:RO_0004028,obo:NCBITaxon_12058,25,realized in response to stimulus,Picornaviridae
obo:RO_0004028,obo:NCBITaxon_775,25,realized in response to stimulus,Rickettsiaceae
obo:RO_0004026,obo:UBERON_0000956,25,disease has location,cerebral cortex
obo:RO_0004026,obo:UBERON_0001707,25,disease has location,nasal cavity
obo:RO_0004026,obo:UBERON_0001765,25,disease has location,mammary duct
obo:RO_0004027,obo:UBERON_0010230,25,disease has inflammation site,eyeball of camera-type eye
obo:RO_0004020,hgnc:6342,24,disease has basis in dysfunction of,KIT
obo:RO_0004021,obo:GO_0006506,24,disease caused by disruption of,GPI anchor biosynthetic process
obo:RO_0004021,obo:GO_0006506,24,disease has basis in disruption of,GPI anchor biosynthetic process
obo:RO_0004029,obo:HP_0000842,24,disease has feature,Hyperinsulinemia
obo:RO_0004029,obo:HP_0001433,24,disease has feature,Hepatosplenomegaly
mondo:disease_causes_feature,obo:HP_0001944,24,disease causes feature,Dehydration
mondo:disease_has_major_feature,obo:HP_0002014,24,disease has major feature,Diarrhea
obo:RO_0004029,obo:HP_0002373,24,disease has feature,Febrile seizures
obo:RO_0004026,obo:UBERON_0000029,24,disease has location,lymph node
obo:RO_0004026,obo:UBERON_0000178,24,disease has location,blood
obo:RO_0004026,obo:UBERON_0000403,24,disease has location,scalp
obo:RO_0004026,obo:UBERON_0001154,24,disease has location,vermiform appendix
obo:RO_0004026,obo:UBERON_0001828,24,disease has location,gingiva
obo:RO_0004026,obo:UBERON_0001894,24,disease has location,diencephalon
obo:RO_0004026,obo:UBERON_0001987,24,disease has location,placenta
obo:RO_0004027,obo:UBERON_0002107,24,disease has inflammation site,liver
obo:RO_0004026,obo:UBERON_0002407,24,disease has location,pericardium
obo:RO_0004020,obo:GO_0005585,23,disease has basis in dysfunction of,collagen type II trimer
obo:BFO_0000054,obo:GO_0046879,23,realized in,hormone secretion
obo:RO_0004029,obo:MONDO_0001147,23,disease has feature,meningocele (disease)
obo:RO_0004029,obo:MONDO_0005478,23,disease has feature,torsades de pointes
obo:RO_0004028,obo:NCBITaxon_780,23,realized in response to stimulus,Rickettsia
obo:RO_0004026,obo:UBERON_0001235,23,disease has location,adrenal cortex
obo:RO_0004026,obo:UBERON_0001621,23,disease has location,coronary artery
obo:RO_0004026,obo:UBERON_0001821,23,disease has location,sebaceous gland
obo:RO_0004026,obo:UBERON_0003100,23,disease has location,female organism
obo:RO_0004030,obo:CL_0002573,22,disease arises from structure,Schwann cell
obo:RO_0004021,obo:GO_0006694,22,disease caused by disruption of,steroid biosynthetic process
obo:RO_0004021,obo:GO_0006694,22,disease has basis in disruption of,steroid biosynthetic process
obo:RO_0004021,obo:GO_0007283,22,disease caused by disruption of,spermatogenesis
obo:RO_0004021,obo:GO_0007283,22,disease has basis in disruption of,spermatogenesis
obo:RO_0004021,obo:GO_0019395,22,disease caused by disruption of,fatty acid oxidation
obo:RO_0004021,obo:GO_0019395,22,disease has basis in disruption of,fatty acid oxidation
mondo:disease_has_major_feature,obo:HP_0001159,22,disease has major feature,Syndactyly
obo:RO_0004029,obo:HP_0001159,22,disease has feature,Syndactyly
obo:RO_0004029,obo:HP_0001700,22,disease has feature,Myocardial necrosis
obo:RO_0004029,obo:HP_0100512,22,disease has feature,Low levels of vitamin D
obo:RO_0004029,obo:HP_0100512,22,disease has feature,Vitamin D deficiency
mondo:predisposes_towards,obo:MONDO_0005550,22,predisposes towards,infectious disease
obo:RO_0004028,obo:NCBITaxon_12059,22,realized in response to stimulus,Enterovirus
obo:RO_0004029,obo:NCIT_C37109,22,disease has feature,Malignant Epithelial Spindle Cell
obo:RO_0004026,obo:UBERON_0001905,22,disease has location,pineal body
obo:RO_0004026,obo:UBERON_0002358,22,disease has location,peritoneum
obo:RO_0009501,obo:ECTO_0001082,21,realized in response to,NA
obo:RO_0004021,obo:GO_0006090,21,disease caused by disruption of,pyruvate metabolic process
obo:RO_0004021,obo:GO_0006090,21,disease has basis in disruption of,pyruvate metabolic process
obo:RO_0004020,obo:GO_0042827,21,disease has basis in dysfunction of,platelet dense granule
obo:RO_0004029,obo:HP_0000238,21,disease has feature,Hydrocephalus
mondo:disease_has_major_feature,obo:HP_0002047,21,disease has major feature,Malignant hyperthermia
obo:RO_0004029,obo:HP_0002094,21,disease has feature,Dyspnea
mondo:disease_has_major_feature,obo:HP_0002486,21,disease has major feature,Myotonia
obo:RO_0004024,obo:NBO_0000034,21,disease disrupts,sexual activity
obo:RO_0004024,obo:NBO_0000034,21,disease causes disruption of,sexual activity
obo:RO_0004024,obo:NBO_0000612,21,disease disrupts,communication behavior
obo:RO_0004024,obo:NBO_0000612,21,disease causes disruption of,communication behavior
obo:RO_0004026,obo:UBERON_0000211,21,disease has location,ligament
obo:RO_0004026,obo:UBERON_0007616,21,disease has location,layer of synovial tissue
obo:RO_0004030,obo:CL_0000031,20,disease arises from structure,neuroblast
obo:RO_0004030,obo:CL_0000354,20,disease arises from structure,blastemal cell
obo:RO_0004020,obo:CL_0000775,20,disease has basis in dysfunction of,neutrophil
obo:RO_0004029,obo:HP_0000939,20,disease has feature,Osteoporosis
obo:RO_0004029,obo:HP_0001276,20,disease has feature,Hypertonia
mondo:disease_has_major_feature,obo:HP_0001679,20,disease has major feature,Abnormal aortic morphology
obo:RO_0004029,obo:MONDO_0006651,20,disease has feature,anterior uveitis (disease)
obo:RO_0004026,obo:UBERON_0000043,20,disease has location,tendon
obo:RO_0004027,obo:UBERON_0000403,20,disease has inflammation site,scalp
obo:RO_0004026,obo:UBERON_0001691,20,disease has location,external ear
obo:RO_0004026,obo:UBERON_0001729,20,disease has location,oropharynx
obo:RO_0004026,obo:UBERON_0001908,20,disease has location,optic tract
obo:RO_0004026,obo:UBERON_0002298,20,disease has location,brainstem
obo:RO_0004030,obo:CL_0000235,19,disease arises from structure,macrophage
obo:RO_0004030,obo:CL_0002293,19,disease arises from structure,epithelial cell of thymus
obo:RO_0009501,obo:ECTO_0000002,19,realized in response to,exposure to electromagnetic radiation
obo:RO_0004021,obo:GO_0000050,19,disease caused by disruption of,urea cycle
obo:RO_0004021,obo:GO_0000050,19,disease has basis in disruption of,urea cycle
obo:RO_0004021,obo:GO_0009311,19,disease caused by disruption of,oligosaccharide metabolic process
obo:RO_0004021,obo:GO_0009311,19,disease has basis in disruption of,oligosaccharide metabolic process
obo:RO_0004029,obo:HP_0000522,19,disease has feature,Alacrima
mondo:disease_has_major_feature,obo:HP_0001635,19,disease has major feature,Congestive heart failure
obo:RO_0004029,obo:HP_0001876,19,disease has feature,Pancytopenia
obo:RO_0004022,obo:MONDO_0005070,19,disease arises from feature,neoplasm (disease)
obo:RO_0004022,obo:MONDO_0005070,19,disease has basis in feature,neoplasm (disease)
obo:RO_0002451,obo:NCBITaxon_6944,19,transmitted by,Ixodes
obo:BFO_0000054,obo:NCIT_C17214,19,realized in,Disease Transmission
obo:RO_0004028,obo:PR_000001886,19,realized in response to stimulus,major prion protein
obo:RO_0004026,obo:UBERON_0000423,19,disease has location,eccrine sweat gland
obo:RO_0004027,obo:UBERON_0001155,19,disease has inflammation site,colon
obo:RO_0004027,obo:UBERON_0001173,19,disease has inflammation site,biliary tree
obo:RO_0004026,obo:UBERON_0001708,19,disease has location,jaw skeleton
obo:RO_0004026,obo:UBERON_0001810,19,disease has location,nerve plexus
obo:RO_0004026,obo:UBERON_0002081,19,disease has location,cardiac atrium
obo:RO_0004026,obo:UBERON_0002082,19,disease has location,cardiac ventricle
obo:RO_0004026,obo:UBERON_0003101,19,disease has location,male organism
obo:RO_0004026,obo:UBERON_0004367,19,disease has location,Descemet's membrane
obo:RO_0004020,hgnc:2200,18,disease has basis in dysfunction of,COL2A1
obo:RO_0004020,hgnc:3512,18,disease has basis in dysfunction of,EXT1
obo:RO_0004024,obo:GO_0007585,18,disease disrupts,respiratory gaseous exchange by respiratory system
obo:RO_0004024,obo:GO_0007585,18,disease disrupts,respiratory gaseous exchange
obo:RO_0004024,obo:GO_0007585,18,disease causes disruption of,respiratory gaseous exchange by respiratory system
obo:RO_0004024,obo:GO_0007585,18,disease causes disruption of,respiratory gaseous exchange
obo:RO_0004021,obo:GO_0042403,18,disease caused by disruption of,thyroid hormone metabolic process
obo:RO_0004021,obo:GO_0042403,18,disease has basis in disruption of,thyroid hormone metabolic process
obo:RO_0004020,obo:GO_0098975,18,disease has basis in dysfunction of,postsynapse of neuromuscular junction
mondo:disease_has_major_feature,obo:HP_0000843,18,disease has major feature,Hyperparathyroidism
mondo:disease_has_major_feature,obo:HP_0001336,18,disease has major feature,Myoclonus
obo:RO_0004029,obo:HP_0002019,18,disease has feature,Constipation
obo:RO_0004029,obo:MONDO_0002203,18,disease has feature,constipation disorder
obo:RO_0004020,obo:PR_000007547,18,disease has basis in dysfunction of,fukutin-related protein
obo:RO_0004027,obo:UBERON_0000945,18,disease has inflammation site,stomach
obo:RO_0004027,obo:UBERON_0001255,18,disease has inflammation site,urinary bladder
obo:RO_0004027,obo:UBERON_0001711,18,disease has inflammation site,eyelid
obo:RO_0004026,obo:UBERON_0001775,18,disease has location,ciliary body
obo:RO_0004026,obo:UBERON_0001817,18,disease has location,lacrimal gland
obo:RO_0004030,obo:UBERON_0001982,18,disease arises from structure,capillary
obo:RO_0004026,obo:UBERON_0002350,18,disease has location,conducting system of heart
obo:RO_0004027,obo:UBERON_0005983,18,disease has inflammation site,heart layer
obo:RO_0004024,obo:GO_0006911,17,disease disrupts,"phagocytosis, engulfment"
obo:RO_0004024,obo:GO_0006911,17,disease causes disruption of,"phagocytosis, engulfment"
obo:RO_0004021,obo:GO_0009069,17,disease caused by disruption of,serine family amino acid metabolic process
obo:RO_0004021,obo:GO_0009069,17,disease has basis in disruption of,serine family amino acid metabolic process
obo:RO_0004021,obo:GO_0009081,17,disease caused by disruption of,branched-chain amino acid metabolic process
obo:RO_0004021,obo:GO_0009081,17,disease has basis in disruption of,branched-chain amino acid metabolic process
obo:RO_0004021,obo:GO_0009235,17,disease caused by disruption of,cobalamin metabolic process
obo:RO_0004021,obo:GO_0009235,17,disease has basis in disruption of,cobalamin metabolic process
obo:RO_0002573,obo:HP_0003621,17,has modifier,Juvenile onset
obo:RO_0004029,obo:HP_0004313,17,disease has feature,Decreased antibody level in blood
obo:RO_0004029,obo:HP_0100502,17,disease has feature,Vitamin B12 deficiency
mondo:disease_has_major_feature,obo:MONDO_0015923,17,disease has major feature,acquired peripheral neuropathy
mondo:disease_has_major_feature,obo:MONDO_0017672,17,disease has major feature,focal palmoplantar keratoderma
obo:RO_0004028,obo:NCBITaxon_10294,17,realized in response to stimulus,Simplexvirus
obo:RO_0004029,obo:NCIT_C53637,17,disease has feature,Malignant Spindle Cell
obo:RO_0004020,obo:PR_000013016,17,disease has basis in dysfunction of,"protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1"
obo:RO_0004026,obo:UBERON_0000382,17,disease has location,apocrine sweat gland
obo:RO_0004027,obo:UBERON_0000474,17,disease has inflammation site,female reproductive system
obo:RO_0004026,obo:UBERON_0001772,17,disease has location,corneal epithelium
obo:RO_0004026,obo:UBERON_0001773,17,disease has location,sclera
obo:RO_0004027,obo:UBERON_0002355,17,disease has inflammation site,pelvic region of trunk
obo:RO_0004026,obo:UBERON_0002418,17,disease has location,cartilage tissue
obo:RO_0004027,obo:UBERON_0008946,17,disease has inflammation site,lung parenchyma
obo:RO_0004027,obo:UBERON_0019207,17,disease has inflammation site,chorioretinal region
obo:RO_0004030,obo:CL_0000185,16,disease arises from structure,myoepithelial cell
mondo:disease_has_major_feature,obo:HP_0000829,16,disease has major feature,Hypoparathyroidism
mondo:disease_has_major_feature,obo:HP_0001392,16,disease has major feature,Abnormality of the liver
obo:RO_0004029,obo:HP_0002721,16,disease has feature,Immunodeficiency
obo:RO_0004028,obo:NCBITaxon_1279,16,realized in response to stimulus,Staphylococcus
obo:RO_0002573,obo:PATO_0002098,16,has modifier,"neoplastic, metastatic"
obo:RO_0004026,obo:UBERON_0001723,16,disease has location,tongue
obo:RO_0004026,obo:UBERON_0001728,16,disease has location,nasopharynx
obo:RO_0004026,obo:UBERON_0002134,16,disease has location,tricuspid valve
obo:RO_0004020,obo:UBERON_0002369,16,disease has basis in dysfunction of,adrenal gland
obo:RO_0004020,hgnc:9884,15,disease has basis in dysfunction of,RB1
obo:RO_0004030,obo:CL_1001428,15,disease arises from structure,bladder urothelial cell
obo:RO_0004021,obo:GO_0006699,15,disease caused by disruption of,bile acid biosynthetic process
obo:RO_0004021,obo:GO_0006699,15,disease has basis in disruption of,bile acid biosynthetic process
obo:RO_0004021,obo:GO_0006826,15,disease caused by disruption of,iron ion transport
obo:RO_0004021,obo:GO_0006826,15,disease has basis in disruption of,iron ion transport
obo:RO_0004021,obo:GO_0061370,15,disease caused by disruption of,testosterone biosynthetic process
obo:RO_0004021,obo:GO_0061370,15,disease has basis in disruption of,testosterone biosynthetic process
obo:RO_0004029,obo:HP_0000750,15,disease has feature,Delayed speech and language development
obo:RO_0004029,obo:HP_0000830,15,disease has feature,Anterior hypopituitarism
mondo:disease_has_major_feature,obo:HP_0001305,15,disease has major feature,Dandy-Walker malformation
mondo:disease_has_major_feature,obo:HP_0001627,15,disease has major feature,Abnormal heart morphology
mondo:disease_has_major_feature,obo:HP_0001880,15,disease has major feature,Eosinophilia
obo:RO_0004028,obo:NCBITaxon_11158,15,realized in response to stimulus,Paramyxoviridae
obo:RO_0004029,obo:NCIT_C45981,15,disease has feature,Presence of a Hormonal Syndrome
obo:RO_0004030,obo:UBERON_0000991,15,disease arises from structure,gonad
obo:RO_0004027,obo:UBERON_0001021,15,disease has inflammation site,nerve
obo:RO_0004026,obo:UBERON_0001174,15,disease has location,common bile duct
obo:RO_0004030,obo:UBERON_0001207,15,disease arises from structure,mucosa of large intestine
obo:RO_0004026,obo:UBERON_0001280,15,disease has location,liver parenchyma
obo:RO_0004026,obo:UBERON_0001833,15,disease has location,lip
obo:RO_0004027,obo:UBERON_0002046,15,disease has inflammation site,thyroid gland
obo:RO_0004026,obo:UBERON_0002196,15,disease has location,adenohypophysis
obo:RO_0004026,obo:UBERON_0004086,15,disease has location,brain ventricle
obo:RO_0004030,obo:UBERON_0006914,15,disease arises from structure,squamous epithelium
obo:RO_0004020,obo:UBERON_0008998,15,disease has basis in dysfunction of,vasculature of brain
obo:RO_0004030,obo:CL_0000451,14,disease arises from structure,dendritic cell
obo:RO_0004021,obo:GO_0001806,14,disease caused by disruption of,type IV hypersensitivity
obo:RO_0004021,obo:GO_0001806,14,disease has basis in disruption of,type IV hypersensitivity
obo:RO_0004021,obo:GO_0006289,14,disease caused by disruption of,nucleotide-excision repair
obo:RO_0004021,obo:GO_0006289,14,disease has basis in disruption of,nucleotide-excision repair
obo:RO_0004021,obo:GO_0015693,14,disease caused by disruption of,magnesium ion transport
obo:RO_0004021,obo:GO_0015693,14,disease has basis in disruption of,magnesium ion transport
obo:RO_0004021,obo:GO_0016126,14,disease caused by disruption of,sterol biosynthetic process
obo:RO_0004021,obo:GO_0016126,14,disease has basis in disruption of,sterol biosynthetic process
obo:RO_0004021,obo:GO_0050667,14,disease caused by disruption of,homocysteine metabolic process
obo:RO_0004021,obo:GO_0050667,14,disease has basis in disruption of,homocysteine metabolic process
obo:RO_0004021,obo:GO_0070914,14,disease caused by disruption of,UV-damage excision repair
obo:RO_0004021,obo:GO_0070914,14,disease has basis in disruption of,UV-damage excision repair
mondo:disease_has_major_feature,obo:HP_0000286,14,disease has major feature,Epicanthus
obo:RO_0004029,obo:HP_0000297,14,disease has feature,Facial hypotonia
obo:RO_0004029,obo:HP_0002072,14,disease has feature,Chorea
mondo:disease_has_major_feature,obo:HP_0011842,14,disease has major feature,Abnormality of skeletal morphology
obo:RO_0002573,obo:HP_0031375,14,has modifier,Refractory
obo:RO_0004029,obo:HP_0100257,14,disease has feature,Ectrodactyly
obo:RO_0004029,obo:HP_0100324,14,disease has feature,Scleroderma
mondo:predisposes_towards,obo:MONDO_0002026,14,predisposes towards,candidiasis
obo:RO_0004029,obo:MONDO_0004617,14,disease has feature,recurrent hypersomnia
obo:RO_0004029,obo:MONDO_0005170,14,disease has feature,myeloid neoplasm
obo:RO_0004029,obo:MONDO_0019289,14,disease has feature,hyperpigmentation of the skin
obo:RO_0004029,obo:MONDO_0021138,14,disease has feature,bone marrow cancer
obo:RO_0004028,obo:NCBITaxon_1485,14,realized in response to stimulus,Clostridium
obo:RO_0004030,obo:UBERON_0000992,14,disease arises from structure,ovary
obo:RO_0004030,obo:UBERON_0000992,14,disease arises from structure,female gonad
obo:RO_0004026,obo:UBERON_0001224,14,disease has location,renal pelvis
obo:RO_0004027,obo:UBERON_0001637,14,disease has inflammation site,artery
obo:RO_0004026,obo:UBERON_0001777,14,disease has location,substantia propria of cornea
obo:RO_0004027,obo:UBERON_0001825,14,disease has inflammation site,paranasal sinus
obo:RO_0004026,obo:UBERON_0002137,14,disease has location,aortic valve
obo:RO_0004026,obo:UBERON_0005305,14,disease has location,thyroid follicle
obo:RO_0004020,hgnc:5009,13,disease has basis in dysfunction of,HMGA2
obo:RO_0004026,obo:CL_0000182,13,disease has location,hepatocyte
obo:RO_0004020,obo:CL_0000573,13,disease has basis in dysfunction of,retinal cone cell
obo:RO_0004021,obo:GO_0009107,13,disease caused by disruption of,lipoate biosynthetic process
obo:RO_0004021,obo:GO_0009107,13,disease has basis in disruption of,lipoate biosynthetic process
obo:RO_0004020,obo:GO_0019814,13,disease has basis in dysfunction of,immunoglobulin complex
obo:RO_0004029,obo:HP_0001510,13,disease has feature,Growth delay
mondo:disease_has_major_feature,obo:HP_0001702,13,disease has major feature,Abnormal tricuspid valve morphology
obo:RO_0004029,obo:HP_0002224,13,disease has feature,Woolly hair
obo:RO_0004029,obo:HP_0002917,13,disease has feature,Hypomagnesemia
obo:RO_0004029,obo:HP_0002960,13,disease has feature,Autoimmunity
obo:RO_0004029,obo:HP_0003510,13,disease has feature,Severe short stature
obo:RO_0004029,obo:HP_0009830,13,disease has feature,Peripheral neuropathy
obo:RO_0004029,obo:HP_0010514,13,disease has feature,Hyperpituitarism
obo:RO_0004022,obo:MONDO_0005187,13,disease arises from feature,human herpesvirus 8 infection
obo:RO_0004022,obo:MONDO_0005187,13,disease has basis in feature,human herpesvirus 8 infection
obo:RO_0004027,obo:UBERON_0000029,13,disease has inflammation site,lymph node
obo:RO_0004027,obo:UBERON_0000042,13,disease has inflammation site,serous membrane
obo:RO_0004026,obo:UBERON_0000058,13,disease has location,duct
obo:RO_0004026,obo:UBERON_0001051,13,disease has location,hypopharynx
obo:RO_0004030,obo:UBERON_0001765,13,disease arises from structure,mammary duct
obo:RO_0004026,obo:UBERON_0002025,13,disease has location,stratum basale of epidermis
obo:RO_0004026,obo:UBERON_0002135,13,disease has location,mitral valve
obo:RO_0004027,obo:UBERON_0003889,13,disease has inflammation site,fallopian tube
obo:RO_0004026,obo:UBERON_0005777,13,disease has location,glomerular basement membrane
obo:RO_0004020,hgnc:10964,12,disease has basis in dysfunction of,SLC22A18
obo:RO_0004020,hgnc:11117,12,disease has basis in dysfunction of,SMN1
obo:RO_0004030,obo:CL_0000182,12,disease arises from structure,hepatocyte
obo:RO_0004030,obo:CL_0000210,12,disease arises from structure,photoreceptor cell
obo:RO_0004021,obo:GO_0006558,12,disease caused by disruption of,L-phenylalanine metabolic process
obo:RO_0004021,obo:GO_0006558,12,disease has basis in disruption of,L-phenylalanine metabolic process
obo:RO_0004021,obo:GO_0007041,12,disease caused by disruption of,lysosomal transport
obo:RO_0004021,obo:GO_0007041,12,disease has basis in disruption of,lysosomal transport
obo:RO_0004021,obo:GO_0007623,12,disease caused by disruption of,circadian rhythm
obo:RO_0004021,obo:GO_0007623,12,disease has basis in disruption of,circadian rhythm
obo:RO_0004024,obo:GO_0045453,12,disease disrupts,bone resorption
obo:RO_0004024,obo:GO_0045453,12,disease causes disruption of,bone resorption
obo:RO_0004029,obo:HP_0000096,12,disease has feature,Glomerulosclerosis
mondo:disease_has_major_feature,obo:HP_0010980,12,disease has major feature,Hyperlipoproteinemia
obo:RO_0004022,obo:MONDO_0005015,12,disease arises from feature,diabetes mellitus (disease)
obo:RO_0004022,obo:MONDO_0005015,12,disease has basis in feature,diabetes mellitus (disease)
mondo:disease_has_major_feature,obo:MONDO_0018912,12,disease has major feature,Cushing syndrome
obo:RO_0004028,obo:NCBITaxon_11617,12,realized in response to stimulus,Arenaviridae
obo:RO_0004028,obo:NCBITaxon_1301,12,realized in response to stimulus,Streptococcus
obo:RO_0004028,obo:NCBITaxon_1535326,12,realized in response to stimulus,Candida <Debaryomycetaceae>
obo:RO_0004028,obo:NCBITaxon_6199,12,realized in response to stimulus,Cestoda
obo:RO_0004029,obo:NCIT_C37123,12,disease has feature,Neoplastic Spindle-Shaped to Round Cell
obo:RO_0004026,obo:UBERON_0000460,12,disease has location,major vestibular gland
obo:RO_0004020,obo:UBERON_0000992,12,disease has basis in dysfunction of,ovary
obo:RO_0004020,obo:UBERON_0000992,12,disease has basis in dysfunction of,female gonad
obo:RO_0004026,obo:UBERON_0001021,12,disease has location,nerve
obo:RO_0004026,obo:UBERON_0001236,12,disease has location,adrenal medulla
obo:RO_0004026,obo:UBERON_0001300,12,disease has location,scrotum
obo:RO_0004027,obo:UBERON_0001758,12,disease has inflammation site,periodontium
obo:RO_0004027,obo:UBERON_0002240,12,disease has inflammation site,spinal cord
obo:RO_0004026,obo:UBERON_0002387,12,disease has location,pes
obo:RO_0004027,obo:UBERON_0003729,12,disease has inflammation site,mouth mucosa
obo:RO_0004030,obo:UBERON_0003902,12,disease arises from structure,retinal neural layer
obo:RO_0004030,obo:UBERON_0004645,12,disease arises from structure,urinary bladder urothelium
obo:RO_0004020,hgnc:3690,11,disease has basis in dysfunction of,FGFR3
obo:RO_0004020,hgnc:6636,11,disease has basis in dysfunction of,LMNA
obo:RO_0004026,obo:CL_0000622,11,disease has location,acinar cell
obo:RO_0004026,obo:CL_0000771,11,disease has location,eosinophil
obo:RO_0004026,obo:CL_0002063,11,disease has location,type II pneumocyte
obo:RO_0004028,obo:FOODON_03315468,11,realized in response to stimulus,shellfish meat (whole or parts)
obo:RO_0004021,obo:GO_0004887,11,disease caused by disruption of,thyroid hormone receptor activity
obo:RO_0004021,obo:GO_0004887,11,disease has basis in disruption of,thyroid hormone receptor activity
obo:RO_0004020,obo:GO_0005592,11,disease has basis in dysfunction of,collagen type XI trimer
obo:RO_0004026,obo:GO_0005604,11,disease has location,basement membrane
obo:RO_0004020,obo:GO_0005750,11,disease has basis in dysfunction of,mitochondrial respiratory chain complex III
obo:RO_0004021,obo:GO_0006206,11,disease caused by disruption of,pyrimidine nucleobase metabolic process
obo:RO_0004021,obo:GO_0006206,11,disease has basis in disruption of,pyrimidine nucleobase metabolic process
obo:RO_0004021,obo:GO_0006560,11,disease caused by disruption of,proline metabolic process
obo:RO_0004021,obo:GO_0006560,11,disease has basis in disruption of,proline metabolic process
obo:RO_0004021,obo:GO_0007499,11,disease caused by disruption of,ectoderm and mesoderm interaction
obo:RO_0004021,obo:GO_0007499,11,disease has basis in disruption of,ectoderm and mesoderm interaction
obo:RO_0004021,obo:GO_0007566,11,disease caused by disruption of,embryo implantation
obo:RO_0004021,obo:GO_0007566,11,disease has basis in disruption of,embryo implantation
obo:RO_0004021,obo:GO_0009066,11,disease caused by disruption of,aspartate family amino acid metabolic process
obo:RO_0004021,obo:GO_0009066,11,disease has basis in disruption of,aspartate family amino acid metabolic process
obo:RO_0004021,obo:GO_0035932,11,disease caused by disruption of,aldosterone secretion
obo:RO_0004021,obo:GO_0035932,11,disease has basis in disruption of,aldosterone secretion
obo:RO_0004021,obo:GO_0071696,11,disease caused by disruption of,ectodermal placode development
obo:RO_0004021,obo:GO_0071696,11,disease has basis in disruption of,ectodermal placode development
obo:RO_0004021,obo:GO_0093001,11,disease caused by disruption of,glycolysis from storage polysaccharide through glucose-1-phosphate
obo:RO_0004021,obo:GO_0093001,11,disease has basis in disruption of,glycolysis from storage polysaccharide through glucose-1-phosphate
obo:RO_0004029,obo:HP_0000230,11,disease has feature,Gingivitis
obo:RO_0004029,obo:HP_0000966,11,disease has feature,Hypohidrosis
obo:RO_0004029,obo:HP_0001249,11,disease has feature,Intellectual disability
obo:RO_0004029,obo:HP_0002148,11,disease has feature,Hypophosphatemia
obo:RO_0004022,obo:HP_0002619,11,disease arises from feature,Varicose veins
obo:RO_0004022,obo:HP_0002619,11,disease has basis in feature,Varicose veins
obo:RO_0004029,obo:HP_0002904,11,disease has feature,Hyperbilirubinemia
obo:RO_0004029,obo:HP_0003351,11,disease has feature,Decreased circulating renin level
obo:RO_0004029,obo:HP_0003470,11,disease has feature,Paralysis
obo:RO_0002573,obo:HP_0003577,11,has modifier,Congenital onset
mondo:disease_has_major_feature,obo:HP_0006517,11,disease has major feature,Alveolar proteinosis
obo:RO_0004029,obo:HP_0011107,11,disease has feature,Recurrent aphthous stomatitis
obo:RO_0004029,obo:HP_0030852,11,disease has feature,High pulse pressure
obo:RO_0004029,obo:MONDO_0001476,11,disease has feature,coloboma
obo:RO_0004029,obo:MONDO_0002082,11,disease has feature,endocrine gland neoplasm
obo:RO_0004029,obo:MONDO_0002508,11,disease has feature,gingivitis
obo:RO_0004029,obo:MONDO_0003664,11,disease has feature,hemolytic anemia
obo:RO_0004029,obo:MONDO_0004603,11,disease has feature,collagenopathy
obo:RO_0004029,obo:MONDO_0017255,11,disease has feature,panuveitis (disease)
obo:RO_0004028,obo:NCBITaxon_10335,11,realized in response to stimulus,Human alphaherpesvirus 3
obo:RO_0004028,obo:NCBITaxon_1280,11,realized in response to stimulus,Staphylococcus aureus
obo:RO_0004028,obo:NCBITaxon_5820,11,realized in response to stimulus,Plasmodium
obo:RO_0004028,obo:NCBITaxon_6236,11,realized in response to stimulus,Rhabditida
obo:RO_0004030,obo:UBERON_0001007,11,disease arises from structure,digestive system
obo:RO_0004027,obo:UBERON_0001043,11,disease has inflammation site,esophagus
obo:RO_0004020,obo:UBERON_0001638,11,disease has basis in dysfunction of,vein
obo:RO_0004026,obo:UBERON_0001645,11,disease has location,trigeminal nerve
obo:RO_0004026,obo:UBERON_0001814,11,disease has location,brachial nerve plexus
obo:RO_0004026,obo:UBERON_0001831,11,disease has location,parotid gland
obo:RO_0004027,obo:UBERON_0002108,11,disease has inflammation site,small intestine
obo:RO_0004026,obo:UBERON_0002165,11,disease has location,endocardium
obo:RO_0004027,obo:UBERON_0002349,11,disease has inflammation site,myocardium
obo:RO_0004026,obo:UBERON_0004913,11,disease has location,hepatopancreatic ampulla
obo:RO_0004026,obo:UBERON_0005989,11,disease has location,atrioventricular septum
obo:RO_0004026,obo:UBERON_0006877,11,disease has location,vasculature of liver
obo:RO_0004026,obo:UBERON_0016525,11,disease has location,frontal lobe
obo:RO_0004020,obo:UBERON_0035965,11,disease has basis in dysfunction of,wall of blood vessel
obo:RO_0004026,obo:UBERON_0036262,11,disease has location,uterine ligament
